English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Summary   Objective  Minimal risk weight loss tools are needed. This study's objective was to confirm Food and Drug Administration submissions of the SmartByte ™  System's safety and efficacy.    Methods  This 16‐week, prospective, single‐arm, four‐centre, observational study assessed the oral device in combination with a video‐delivered lifestyle programme in adults aged 18–49 years with body mass index 27 to <35 kg m −2 .    Results  Seventy‐six subjects received the device and video lifestyle instruction. The prespecified per protocol (PP) population ( N  = 40) required sensor‐verified use of the device ≥7 times per week for 14 of 16 weeks, overall device usage rate of ≥33% and study completion. At week 16, 12 (30%) achieved ≥5% weight loss, 16 (40%) achieved ≥4% and 21 (52.5%) achieved ≥3%. Week 16 mean loss for the PP population was 2.93%, and among 36 participants who did not meet PP criteria, it was 1.45%. Among 76 intent‐to‐treat subjects, two subjects reported three mild to moderate device‐related adverse events, resolving spontaneously (one hard palate abrasion and two tongue lacerations).    Conclusion  The System, a minimal risk tool, can help individuals achieve meaningful weight loss, when used with a lifestyle video. More frequent device use was associated with more weight loss, on average, and greater chance of achieving ≥4% or ≥5% weight loss.

Efficacy and safety of an oral device to reduce food intake and promote weight loss